Stay updated with breaking news from Simoa Technology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Operator: Good day and thank you for standing by. Welcome to the Quanterix Corporation Q3 2023 Earnings Call. At this time, all participants are in a listen-only mode.
Investors gave the thumbs-down to the biotech's latest reported quarter.
Quanterix Receives FDA Emergency Use Authorization for SARS-CoV-2 N Protein Antigen Test Quanterix Receives FDA Emergency Use Authorization for SARS-CoV-2 N Protein Antigen Test Quanterix Corporation (NASDAQ:QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced that the Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for its Simoa SARS-CoV-2 N Protein Antigen Test that can be run on the Simoa HD-X Analyzer, a fully automated high-throughput immunoassay instrument. The Simoa SARS-CoV-2 N Protein Antigen...